---
title: "LISBURN PHARMA LIMITED — Ownership Dossier"
canonical: https://whiteintel.dev/entity/8deed303-96dd-5c32-8bb0-2df3a2c8481e
json: https://whiteintel.dev/api/public/dossier/8deed303-96dd-5c32-8bb0-2df3a2c8481e
identifier: oo:GB-COH-NI654966
jurisdiction: GB
risk: Low
source: WhiteIntel corporate-ownership graph
---

# LISBURN PHARMA LIMITED

**Type:** Company  
**Jurisdiction:** [GB](https://whiteintel.dev/jurisdictions/gb)  
**Identifier:** `oo:GB-COH-NI654966`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/8deed303-96dd-5c32-8bb0-2df3a2c8481e  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/8deed303-96dd-5c32-8bb0-2df3a2c8481e  

## Ownership & control

### Owners / controllers

- **Carnbane Health Limited** (beneficial owner) — 37.5% — https://whiteintel.dev/entity/bc7c4d23-317c-428f-9547-ad5771ea789e
- **Kajima Partnerships Limited** (beneficial owner) — 37.5% — https://whiteintel.dev/entity/f8224c4a-5dea-4eef-9f30-253384fb0b87

### UBO chain (walk to the ultimate owner)

A **15-step** ownership/control chain to the ultimate beneficial owner is resolved for this entity. The full cited chain unlocks with a paid API key or a one-off dossier — https://whiteintel.dev/pricing.

## Company profile (live · UK Companies House)

- **Company number:** `NI654966`
- **Status:** active
- **Type:** ltd
- **Incorporated:** 2018-08-10
- **Registered office:** Carnbane House Shepherds Way, Carnbane Industrial Estate, Newry, BT35 6EE, United Kingdom
- **SIC:** 68209

### Officers

- BELL, Samantha — secretary · appointed 2025-11-01
- ALLARD, Tyrone James — director · Irish · appointed 2024-01-31
- HAWKINS, Kevin Stuart — director · British · appointed 2023-04-26
- O'HARE, Cathal Edward James — director · Irish · appointed 2025-05-28
- PHILLIPS, Christine — director · British · appointed 2024-07-10
- CHISM, Nigel William Michael Goddard — director · British · appointed 2021-06-30 · resigned 2024-07-10
- DUFFY, Patrick Matthew — director · Northern Irish · appointed 2018-08-10 · resigned 2024-01-31
- O'HARE, Eamon — director · Irish · appointed 2018-08-10 · resigned 2024-10-24
- PATEL, Jitesh Kumar — director · British · appointed 2018-08-10 · resigned 2021-06-30
- TAYLOR, Kirk Graham Vaughan — director · British · appointed 2018-08-10 · resigned 2023-04-26

### Beneficial owners (Persons with Significant Control)

- Kajima Partnerships Limited — 25–50% shares · corporate PSC · United Kingdom — since 2018-08-10
- Carnbane Health Limited — 25–50% shares · corporate PSC · United Kingdom — since 2018-08-10

## Provenance

- OpenOwnership — https://find-and-update.company-information.service.gov.uk/company/NI654966
- companies_house_bulk — https://find-and-update.company-information.service.gov.uk/company/NI654966

## Get the full, resolved dossier (agent-callable)

The above is the free teaser. The resolved **multi-hop UBO chain**, ownership **%**, full **financial history**, itemised **assets** and the hop-by-hop **exposure path** are the paid depth — callable as tools from your agent:

```bash
npx -y @whiteintel/mcp-server   # then: get_dossier · trace_ownership_path · check_offshore_exposure
```

Or unlock a one-off cited dossier for **LISBURN PHARMA LIMITED** — https://whiteintel.dev/entity/8deed303-96dd-5c32-8bb0-2df3a2c8481e · pricing https://whiteintel.dev/pricing.

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **LISBURN PHARMA LIMITED**. Human view: https://whiteintel.dev/entity/8deed303-96dd-5c32-8bb0-2df3a2c8481e · Structured JSON: https://whiteintel.dev/api/public/dossier/8deed303-96dd-5c32-8bb0-2df3a2c8481e._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._